US 11,969,576 B2
Methods of incorporating CGM data into diabetes therapy
Michael Michaud, San Diego, CA (US); Garrett Marin, San Diego, CA (US); Geoffrey A. Kruse, San Diego, CA (US); Jacob Kearns, San Diego, CA (US); Thomas R. Ulrich, Oceanside, CA (US); Trevor Denbo, San Diego, CA (US); and David Berger, San Diego, CA (US)
Assigned to Tandem Diabetes Care, Inc., San Diego, CA (US)
Filed by Tandem Diabetes Care, Inc., San Diego, CA (US)
Filed on Jul. 6, 2020, as Appl. No. 16/920,895.
Claims priority of provisional application 62/870,385, filed on Jul. 3, 2019.
Prior Publication US 2021/0001044 A1, Jan. 7, 2021
Int. Cl. A61M 5/172 (2006.01)
CPC A61M 5/1723 (2013.01) [A61M 2205/3553 (2013.01); A61M 2205/3569 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/505 (2013.01); A61M 2230/201 (2013.01)] 20 Claims
OG exemplary drawing
 
1. An ambulatory infusion pump system, comprising:
a pump mechanism configured to facilitate delivery of insulin to a user;
a user interface;
a communications device adapted to receive glucose levels from a continuous glucose monitor;
a processor functionally linked to the pump mechanism, the user interface and the communications device, the processor configured to:
automatically calculate insulin doses with a closed loop delivery algorithm based on glucose levels received from the continuous glucose monitor;
deliver the calculated insulin doses to the user with the pump mechanism;
display a bolus programming feature for programming a bolus delivery of insulin to the user;
determine whether the closed loop delivery algorithm supports an auto-population feature;
determine whether a current glucose level received from the continuous glucose monitor is valid; and
activate the auto-population feature to automatically populate a blood glucose field in the bolus programming feature with a most recent glucose level received from the continuous glucose monitor only if the closed loop delivery algorithm supports the auto-population feature, the current glucose level received from the continuous glucose monitor is valid, and a rate of change of glucose levels received from the continuous glucose monitor satisfies a certain defined threshold.